9081 EIKCS Activity Evaluation

6. Please rate your ability BEFORE the activity *This question is required.

Space Cell	0-Not Relevant	1-Low	2	3	4	5-High
ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 0-Not Relevant	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 1-Low	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 2	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 3	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 4	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 5-High
ABILITY to identify the novel approaches to non-clear RCC patient management	ABILITY to identify the novel approaches to non-clear RCC patient management : 0-Not Relevant	ABILITY to identify the novel approaches to non-clear RCC patient management : 1-Low	ABILITY to identify the novel approaches to non-clear RCC patient management : 2	ABILITY to identify the novel approaches to non-clear RCC patient management : 3	ABILITY to identify the novel approaches to non-clear RCC patient management : 4	ABILITY to identify the novel approaches to non-clear RCC patient management : 5-High
ABILITY to understand the role of the tumor microenvironment in kidney cancer	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 0-Not Relevant	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 1-Low	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 2	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 3	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 4	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 5-High
ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 0-Not Relevant	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 1-Low	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 2	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 3	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 4	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 5-High

7. Please rate your ability AFTER the activity *This question is required.

Space Cell	0-Not Relevant	1-Low	2	3	4	5-High
ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 0-Not Relevant	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 1-Low	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 2	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 3	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 4	ABILITY to characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma: 5-High
ABILITY to identify the novel approaches to non-clear RCC patient management	ABILITY to identify the novel approaches to non-clear RCC patient management : 0-Not Relevant	ABILITY to identify the novel approaches to non-clear RCC patient management : 1-Low	ABILITY to identify the novel approaches to non-clear RCC patient management : 2	ABILITY to identify the novel approaches to non-clear RCC patient management : 3	ABILITY to identify the novel approaches to non-clear RCC patient management : 4	ABILITY to identify the novel approaches to non-clear RCC patient management : 5-High
ABILITY to understand the role of the tumor microenvironment in kidney cancer	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 0-Not Relevant	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 1-Low	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 2	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 3	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 4	ABILITY to understand the role of the tumor microenvironment in kidney cancer : 5-High
ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 0-Not Relevant	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 1-Low	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 2	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 3	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 4	ABILITY to discuss how to design biomarker driven clinical trials in kidney cancer : 5-High

8. Do you intend to make changes or apply new knowledge to your practice as a result of this activity? *This question is required.

• Yes*
• I’m possibly considering changes*
• This activity affirms what I already do in practice
• No, I do not intend to make any changes†

If you answered yes or possibly considering changes, please check off what you intend to do differently or incorporate into your clinical management of patients as a result of this educational activity. *This question is required.

• Select appropriate therapies for locally advanced and metastatic renal cell carcinoma
• Incorporate novel approaches to non-clear RCC patient management
• Other, please specify Please enter an 'other' value for this selection.